Dyne Therapeutics (DYN) Stock Highlights

9.91 | +6.22%

2025-04-23 05:25:43

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Statistics

Range Today

9.3 10.11

Volume Today 3.26M

Range 1 Year

6.36 47.45

Volume 1 Year 374.93M

Range 3 Year

4.3 47.45

Volume 3 Year 692.6M

Range 10 Year

4.3 47.45

Volume 10 Year 803.91M

Highlights

Market Capitalization 928.39M (small)

Floating Shares 97.28M

Current Price 9.91

Price To Earnings -2.32

Price To Book 1.33

Earnings Per Share -3.37

Payout Ratio 0%

Performance

Latest +6.22%

1 Month -18.17%

3 Months -31.94%

6 Months -69.8%

1 Year -59.18%

3 Years +12.74%

5 Years -56.13%

10 Years -56.13%

Benchmarks

Market Capitalization

82 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

312 / 368

Free Cashflow

296 / 352

Performance 5 years

178 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.